Oncoproteins that commonly mutate or genetically alter in cancer cells, including the oncogenic KRAS, oncogenic BRAF, and activated PI3K/AKT, have been shown to result in glucose metabolic reprogramming in cancer cells (Figure 2) [41]. The gene discussed is KRAS; the disease is cancer.